Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,607 | -11,251 | -7,760 | -101,875 | -24,625 |
| Depreciation Amortization | 443 | 251 | 120 | 256 | 142 |
| Accounts receivable | 33 | -2 | 15 | -352 | 63 |
| Accounts payable and accrued liabilities | 8,726 | 5,962 | 2,573 | 1,002 | 630 |
| Other Working Capital | 10,335 | 7,326 | 3,425 | 1,066 | -2,366 |
| Other Operating Activity | -9,661 | -6,217 | -2,135 | 71,710 | 5,321 |
| Operating Cash Flow | $-4,732 | $-3,930 | $-3,762 | $-28,193 | $-20,834 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -7 | -7 | -183 | -86 |
| Net Acquisitions | N/A | N/A | N/A | 13,646 | 13,646 |
| Investing Cash Flow | $-7 | $-7 | $-7 | $13,463 | $13,560 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | N/A | N/A | N/A | 200 |
| Debt Issued | 500 | 500 | N/A | 14,871 | 14,671 |
| Debt Repayment | -9,304 | -9,304 | -9,304 | -898 | -98 |
| Common Stock Issued | 7,117 | 6,405 | 6,457 | 7,344 | 6,455 |
| Common Stock Repurchased | N/A | N/A | -51 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -329 | -329 |
| Financing Cash Flow | $-1,687 | $-2,398 | $-2,899 | $20,988 | $20,898 |
| Exchange Rate Effect | 86 | 44 | -26 | -7 | -2 |
| Beginning Cash Position | 6,845 | 6,845 | 6,845 | 594 | 594 |
| End Cash Position | 506 | 554 | 152 | 6,845 | 14,216 |
| Net Cash Flow | $-6,339 | $-6,291 | $-6,693 | $6,251 | $13,623 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,732 | -3,930 | -3,762 | -28,193 | -20,834 |
| Capital Expenditure | -7 | -7 | -7 | -183 | -86 |
| Free Cash Flow | -4,738 | -3,937 | -3,768 | -28,376 | -20,920 |